
Nyxoah S.A (NYXH) | Financial Analysis & Statements
Nyxoah S.A. | Mid-cap | Healthcare
Nyxoah S.A. | Mid-cap | Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
1.1M
Gross Profit
658.0K
61.84%
Operating Income
-20.6M
-1,939.76%
Net Income
-22.4M
-2,103.76%
EPS (Diluted)
€-0.60
Balance Sheet Metrics
Total Assets
135.9M
Total Liabilities
43.1M
Shareholders Equity
92.8M
Debt to Equity
0.46
Cash Flow Metrics
Operating Cash Flow
-14.1M
Free Cash Flow
-13.7M
Revenue & Profitability Trend
Nyxoah S.A Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 4.5M | 4.3M | 3.1M | 852.0K | 69.0K |
Cost of Goods Sold | 1.6M | 1.7M | 1.2M | 303.0K | 30.0K |
Gross Profit | 3.0M | 2.7M | 1.9M | 549.0K | 39.0K |
Gross Margin % | 65.7% | 61.9% | 62.7% | 64.4% | 56.5% |
Operating Expenses | |||||
Research & Development | 34.4M | 27.7M | 16.0M | 13.0M | 2.3M |
Selling, General & Administrative | 27.2M | 20.6M | 17.9M | 14.0M | 8.8M |
Other Operating Expenses | -1.1M | -1.5M | -406.0K | -880.0K | -459.0K |
Total Operating Expenses | 60.5M | 46.8M | 33.5M | 26.1M | 10.7M |
Operating Income | -58.8M | -45.1M | -32.5M | -26.2M | -11.2M |
Operating Margin % | -1,300.8% | -1,037.3% | -1,053.8% | -3,080.0% | -16,266.7% |
Non-Operating Items | |||||
Interest Income | 2.5M | 2.6M | 372.0K | 1.0K | 3.0K |
Interest Expense | 886.0K | 217.0K | 237.0K | 386.0K | 198.0K |
Other Non-Operating Income | 1.8M | -925.0K | 2.9M | 3.2M | 39.0K |
Pre-tax Income | -56.4M | -44.7M | -30.1M | -24.6M | -12.2M |
Income Tax | 2.8M | -1.4M | 1.2M | 3.0M | 93.0K |
Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Net Income | -59.2M | -43.2M | -31.2M | -27.6M | -12.2M |
Net Margin % | -1,310.2% | -993.8% | -1,012.5% | -3,241.7% | -17,746.4% |
Key Metrics | |||||
EBITDA | -54.6M | -41.2M | -30.8M | -25.8M | -11.4M |
EPS (Basic) | €-1.81 | €-1.55 | €-1.21 | €-1.16 | €-0.68 |
EPS (Diluted) | €-1.81 | €-1.55 | €-1.21 | €-1.16 | €-0.68 |
Basic Shares Outstanding | 32743605 | 27968142 | 25827130 | 23809483 | 18097988 |
Diluted Shares Outstanding | 32743605 | 27968142 | 25827130 | 23809483 | 18097988 |
Income Statement Trend
Nyxoah S.A Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 34.2M | 21.6M | 17.9M | 135.5M | 92.3M |
Short-term Investments | 51.4M | 36.1M | 77.0M | 0 | - |
Accounts Receivable | 3.4M | 2.8M | 1.5M | 226.0K | 0 |
Inventory | 4.7M | 3.3M | 882.0K | 346.0K | 55.0K |
Other Current Assets | 1.7M | 1.3M | 1.3M | 1.7M | 109.0K |
Total Current Assets | 98.1M | 68.4M | 100.3M | 140.1M | 94.1M |
Non-Current Assets | |||||
Property, Plant & Equipment | 1.9M | 1.5M | 1.2M | 858.0K | 164.0K |
Goodwill | 50.4M | 46.6M | 40.0M | 25.3M | 15.9M |
Intangible Assets | 50.4M | 46.6M | 40.0M | 25.3M | 15.9M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 1.7M | 1.2M | 220.0K | 210.0K | 122.0K |
Total Non-Current Assets | 60.3M | 55.8M | 45.8M | 30.8M | 20.0M |
Total Assets | 158.4M | 124.2M | 146.1M | 170.8M | 114.1M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 3.7M | 4.1M | 1.9M | 2.4M | 815.0K |
Short-term Debt | 1.4M | 1.2M | 1.1M | 1.1M | 1.1M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 1.5M | 90.0K | 9.0K | 654.0K | - |
Total Current Liabilities | 21.5M | 14.4M | 14.9M | 11.6M | 6.4M |
Non-Current Liabilities | |||||
Long-term Debt | 21.3M | 11.5M | 10.8M | 10.5M | 10.5M |
Deferred Tax Liabilities | 19.0K | 9.0K | 0 | 5.0K | 0 |
Other Non-Current Liabilities | 845.0K | - | - | - | - |
Total Non-Current Liabilities | 23.6M | 11.7M | 10.8M | 10.6M | 10.5M |
Total Liabilities | 45.2M | 26.1M | 25.7M | 22.2M | 16.9M |
Equity | |||||
Common Stock | 6.4M | 4.9M | 4.4M | 4.4M | 3.8M |
Retained Earnings | -217.7M | -160.8M | -118.2M | -87.2M | -60.3M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 113.3M | 98.0M | 120.3M | 148.6M | 97.2M |
Key Metrics | |||||
Total Debt | 22.7M | 12.7M | 11.9M | 11.7M | 11.5M |
Working Capital | 76.6M | 53.9M | 85.3M | 128.5M | 87.7M |
Balance Sheet Composition
Nyxoah S.A Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | -56.4M | -44.7M | -30.1M | -24.6M | -12.2M |
Depreciation & Amortization | 2.7M | 2.4M | 1.9M | 1.7M | 620.0K |
Stock-Based Compensation | 4.0M | 2.6M | 2.7M | 1.3M | 2.5M |
Working Capital Changes | -2.2M | -4.0M | -529.0K | -2.8M | 310.0K |
Operating Cash Flow | -52.8M | -44.7M | -29.0M | -26.7M | -7.9M |
Investing Activities | |||||
Capital Expenditures | -1.2M | -2.5M | -886.0K | -1.5M | -562.0K |
Acquisitions | - | - | - | - | - |
Investment Purchases | -97.8M | -80.0M | -102.6M | 0 | -13.0K |
Investment Sales | 85.3M | 120.7M | 28.9M | 0 | 0 |
Investing Cash Flow | -13.7M | 38.2M | -74.6M | -1.5M | -575.0K |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | 0 | 0 | 0 | 0 | 0 |
Debt Issuance | 10.0M | - | 0 | 0 | 1.2M |
Debt Repayment | -1.5M | -1.2M | -1.1M | -863.0K | -597.0K |
Financing Cash Flow | 77.9M | 17.0M | -853.0K | 76.9M | 104.2M |
Free Cash Flow | -55.3M | -55.7M | -45.1M | -37.2M | -17.5M |
Net Change in Cash | 11.4M | 10.5M | -104.4M | 48.7M | 95.7M |
Cash Flow Trend
Nyxoah S.A Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
-3.59
Forward P/E
-3.76
Price to Book
2.62
Price to Sales
56.55
PEG Ratio
-3.76
Profitability Ratios
Profit Margin
65.67%
Operating Margin
-1,939.76%
Return on Equity
-77.44%
Return on Assets
-33.76%
Financial Health
Current Ratio
3.59
Debt to Equity
23.79
Beta
0.65
Per Share Data
EPS (TTM)
€-1.99
Book Value per Share
€2.48
Revenue per Share
€0.13
Peer Financial Comparison
Financial data is updated regularly. All figures are in the company's reporting currency.